Cite
HARVARD Citation
Regnier-Gavier, O. et al. (n.d.). Recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC): What about second-line chemotherapy combining cetuximab and platinum-doublet after EXTREME protocol?. European journal of cancer. pp. S113-. [Online].